₹69.65 Crores | Listing at BSE | Fri, May 8, 2026 - Mon, May 18, 2026
Innovassynth Technologies (india) Ltd Rights Issue comprises 1.74 Cr equity shares aggregating to ₹69.65 Cr, offered at an issue price of ₹40 per share with a face value of ₹10 per share.
The record date for determining eligible shareholders is Apr 29, 2026, with the Rights Issue being offered in the entitlement ratio of 3:13.
As per the terms of payment, ₹40 per share payable in full at the time of application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Apr 30, 2026.
The Rights Issue opens on May 8, 2026 and closes on May 18, 2026.
The deemed date of allotment is May 19, 2026, following which the equity shares are expected to be credited to demat accounts on May 20, 2026 and listed on the BSE on May 21, 2026.
MUFG Intime India Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Innovassynth Technologies (india) Ltd Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Wed, Apr 29, 2026
Entitlement Ratio
3 : 13
Open Date
Fri, May 8, 2026
Close Date
Mon, May 18, 2026
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 48.60 | 41.22 | |
| Total Income | 22.08 | ||
| Profit After Tax | -7.80 | -4.69 | -0.84 |
| NET Worth | 41.73 | 33.35 | 43.36 |
| Total Borrowing | 32.88 | 6.16 | |
| Amount in ₹ Crore | |||
Incorporated in 2001, Innovassynth Technologies (India) Limited is a speciality chemicals company. The company operates in the chemical manufacturing sector, focusing on research-driven and high-value chemical solutions.
The company is engaged in the development, scale-up, and manufacturing of specialty chemicals and pharmaceutical intermediates. Its core business areas include custom synthesis, contract research and manufacturing (CRAMS), and toll manufacturing, catering to global pharmaceutical, biotech, and chemical companies.
Innovassynth also specializes in advanced products such as nucleosides, phosphonamidites, and other intermediates used in clinical, diagnostic, and therapeutic applications. With strong R&D capabilities and modern laboratory infrastructure, the company serves industries like pharmaceuticals, agrochemicals, and specialty materials.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Pre-Payment of Loan in full availed from ICICI Bank Limited | 44.00 |
| 2 | To augment the existing and incremental working capital requirement of the Company | 8.50 |
| 3 | To meet General Corporate Purposes | 16.32 |
| Total | 68.82 |
[Dilip Davda] ITIL is engaged in developing, scaling up and manufacturing of speciality chemicals and pharma intermediates. It marked losses for the reported periods amidst merger process. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears aggressively priced. Considering offer at around 38+% discount, only well-informed/risk seekers/cash surplus investors may park moderate funds for medium term. Read detail review...
Innovassynth Technologies Rights Issue 2026 got oversubscribed by 1.55 times by the end of the bidding period with total bid quantity received by BSE of 2,70,38,976 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | Subscription Times |
|---|---|---|
May 18 2026 17:00:00 | 2,70,38,976 | 1.55x |
Innovassynth Technologies (india) Ltd
Old Mumbai–Pune Road,
Khopoli, Raigarh
Khopoli, 410203
The Innovassynth Technologies Rights Issue 2026 opens on Fri, May 8, 2026, and closes on Mon, May 18, 2026.
Innovassynth Technologies Rights Issue 2026 Schedule
| Last Date for credit of Rights Entitlements | Thu, Apr 30, 2026 |
| Last Date for renunciation of Rights Entitlements | Tue, May 12, 2026 |
| Issue Opening Date | Fri, May 8, 2026 |
| Issue Closing Date | Mon, May 18, 2026 |
| Date of Allotment (on or about) | Tue, May 19, 2026 |
| Date of Credit (on or about) | Wed, May 20, 2026 |
| Date of Listing (on or about) | Thu, May 21, 2026 |
You can apply for Innovassynth Technologies Rights Issue 2026 in two ways:
Steps to apply for Innovassynth Technologies Rights Issue 2026 using Net Banking (ASBA)
Steps to apply for Innovassynth Technologies Rights Issue 2026 using Registrar's website (R-WAP)
